Literature DB >> 33773941

Prevalence of obesity and associated cardiovascular risk factors in the Spanish population: the ENPE study.

Carmen Pérez-Rodrigo1, Gotzone Hervás Bárbara2, Marta Gianzo Citores2, Javier Aranceta-Bartrina3.   

Abstract

INTRODUCTION AND
OBJECTIVES: Obesity is a significant public health problem associated with an increased risk of cardiovascular risk factors (CVRF). The aim of this study was to determine the prevalence of overweight and abdominal obesity (AO) in the Spanish population aged ≥ 3 years and to analyze the influence of sociodemographic and lifestyle factors and their association with CVRF.
METHODS: The sample was drawn from the ENPE study (n=6800). The study protocol included individual anthropometric measurements, sociodemographic factors, food intake (food frequency questionnaire), physical activity, lifestyles, and health problems.
RESULTS: The estimated overall prevalence of obesity (22.0%; 95%CI, 21.0-23.0) and AO (64.7%; 95%CI, 63.5-65.8) was higher in men, in persons aged ≥ 65 years, and in those with a lower socioeconomic level or from southern regions. Lifestyle pattern was significantly associated with obesity and AO (P=.011), which were less likely in people with an active lifestyle pattern (P <.0001). Obesity (OR, 1.85; 95%CI, 1.24-2.78) and AO (OR, 2.16; 95%CI, 1.1-4.24) were positively associated with CVRF. Clustering of CVRF with obesity and/or AO was higher in women (12.6%; 95%CI, 11.4-13.9) and in persons aged ≥ 65 years (32.7%; 95%CI, 30.0-35.4).
CONCLUSIONS: The prevalence of obesity and AO in the Spanish population is high; it is higher in men, increases with age, and is inversely related to socioeconomic status. A lifestyle pattern combining a higher level of physical activity, moderate sedentariness and a Mediterranean dietary pattern is associated with a lower probability of obesity, AO, and CVRF.
Copyright © 2020 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Abdominal obesity; Cardiovascular risk factors; Estilo de vida; Factores de riesgo cardiovascular; Lifestyle; Obesidad; Obesidad abdominal; Obesity

Mesh:

Year:  2021        PMID: 33773941     DOI: 10.1016/j.rec.2020.12.020

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  6 in total

1.  Is Dog Owner Obesity a Risk Factor for Canine Obesity? A "One-Health" Study on Human-Animal Interaction in a Region with a High Prevalence of Obesity.

Authors:  Lourdes Suarez; Inmaculada Bautista-Castaño; Cristina Peña Romera; José Alberto Montoya-Alonso; Juan Alberto Corbera
Journal:  Vet Sci       Date:  2022-05-22

2.  Dietary Calcium Intake and Fat Mass in Spanish Young Adults: The Role of Muscle Strength.

Authors:  Ana Torres-Costoso; Vicente Martínez-Vizcaíno; Rubén Fernández-Rodríguez; Irene Sequí-Dominguez; Sara Reina-Gutiérrez; Sergio Núñez de Arenas-Arroyo; Miriam Garrido-Miguel
Journal:  Nutrients       Date:  2021-12-16       Impact factor: 5.717

3.  Public Opinion on Food Policies to Combat Obesity in Spain.

Authors:  Cristina Cavero Esponera; Sara Fernández Sánchez-Escalonilla; Miguel Ángel Royo-Bordonada
Journal:  Int J Environ Res Public Health       Date:  2022-07-13       Impact factor: 4.614

Review 4.  Probiotics and Gut Microbiota in Obesity: Myths and Realities of a New Health Revolution.

Authors:  Xavier Eugenio León Aguilera; Alexander Manzano; Daniela Pirela; Valmore Bermúdez
Journal:  J Pers Med       Date:  2022-08-04

5.  Risk of Hypertension and Use of Antihypertensive Drugs in the Physically Active Population under-70 Years Old-Spanish Health Survey.

Authors:  Ángel Denche-Zamorano; Jorge Pérez-Gómez; Maria Mendoza-Muñoz; Jorge Carlos-Vivas; Rafael Oliveira; João Paulo Brito
Journal:  Healthcare (Basel)       Date:  2022-07-11

6.  Healthy beverages may reduce the genetic risk of abdominal obesity and related metabolic comorbidities: a gene-diet interaction study in Iranian women.

Authors:  Fatemeh Gholami; Mahsa Samadi; Neda Soveid; Khadijeh Mirzaei
Journal:  Diabetol Metab Syndr       Date:  2022-09-27       Impact factor: 5.395

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.